172 related articles for article (PubMed ID: 27428195)
1. Positive association of female overactive bladder symptoms and estrogen deprivation: A nationwide population-based cohort study in Taiwan.
Cheng CL; Li JR; Lin CH; de Groat WC
Medicine (Baltimore); 2016 Jul; 95(28):e4107. PubMed ID: 27428195
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study.
Lin FY; Yang YC; Lin CL; Lee LJ
PLoS One; 2018; 13(3):e0193783. PubMed ID: 29499067
[TBL] [Abstract][Full Text] [Related]
3. Positive Association of Male Overactive Bladder Symptoms and Androgen Deprivation: A Nationwide Population-based Cohort Study.
Li JR; Wang SS; Lin CH; DE Groat WC; Cheng CL
Anticancer Res; 2019 Jan; 39(1):305-311. PubMed ID: 30591473
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.
Chuang YC; Liu SP; Lee KS; Liao L; Wang J; Yoo TK; Chu R; Sumarsono B
Low Urin Tract Symptoms; 2019 Jan; 11(1):48-55. PubMed ID: 28967230
[TBL] [Abstract][Full Text] [Related]
5. Risk of psychiatric disorders in overactive bladder syndrome: a nationwide cohort study in Taiwan.
Tzeng NS; Chang HA; Chung CH; Kao YC; Yeh HW; Yeh CB; Chiang WS; Huang SY; Lu RB; Chien WC
J Investig Med; 2019 Feb; 67(2):312-318. PubMed ID: 30275006
[TBL] [Abstract][Full Text] [Related]
6. Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System.
Rashid N; Vassilakis M; Lin KJ; Kristy R; Ng DB
J Manag Care Spec Pharm; 2017 Apr; 23(4):484-493. PubMed ID: 28345439
[TBL] [Abstract][Full Text] [Related]
7. Antimuscarinic Use in Females With Overactive Bladder Syndrome Increases the Risk of Depressive Disorder: A 3-Year Follow-up Study.
Chung SD; Weng SS; Huang CY; Lin HC; Kao LT
J Clin Pharmacol; 2017 Aug; 57(8):1064-1070. PubMed ID: 28378881
[TBL] [Abstract][Full Text] [Related]
8. Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting.
Asche CV; Kim J; Kulkarni AS; Chakravarti P; Andersson KE
BJU Int; 2012 Feb; 109(4):572-80. PubMed ID: 21777361
[TBL] [Abstract][Full Text] [Related]
9. No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.
Kao LT; Huang CY; Lin HC; Chu CM
J Clin Pharmacol; 2018 Jun; 58(6):727-732. PubMed ID: 29315618
[TBL] [Abstract][Full Text] [Related]
10. Overactive bladder in an integrated delivery system: a longitudinal cohort study.
Linder JA; Weissman JS; Reyes Nieva H; Lipsitz S; Haring RS; DeAngelis J; Kristy RM; Loughlin KR
BMC Health Serv Res; 2020 May; 20(1):447. PubMed ID: 32434511
[TBL] [Abstract][Full Text] [Related]
11. A community-based epidemiological survey of overactive bladder and voiding dysfunction in female Taiwanese residents aged 40 years and above.
Ng SC; Hu SW; Chen GD
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):811-814. PubMed ID: 29241925
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for new-onset overactive bladder in older subjects: results of the Fujiwara-kyo study.
Hirayama A; Torimoto K; Mastusita C; Okamoto N; Morikawa M; Tanaka N; Fujimoto K; Yoshida K; Hirao Y; Kurumatani N
Urology; 2012 Jul; 80(1):71-6. PubMed ID: 22626577
[TBL] [Abstract][Full Text] [Related]
13. Real-world characteristics of elderly patients with overactive bladder in the United States.
Ganz ML; Liu J; Zou KH; Bhagnani T; Luo X
Curr Med Res Opin; 2016 Dec; 32(12):1997-2005. PubMed ID: 27645532
[TBL] [Abstract][Full Text] [Related]
14. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study.
Hallas J; Margulis AV; Pottegård A; Kristiansen NS; Atsma WJ; Appenteng K; de Vogel S; Kaye JA; Perez-Gutthann S; Arana A
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):612-619. PubMed ID: 29345103
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women.
Kim SY; Bang W; Choi HG
PLoS One; 2017; 12(9):e0185592. PubMed ID: 28957446
[TBL] [Abstract][Full Text] [Related]
17. Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjögren's syndrome patients: A nationwide population-based study.
Lee CK; Tsai CP; Liao TL; Huang WN; Chen YH; Lin CH; Chen YM
PLoS One; 2019; 14(11):e0225455. PubMed ID: 31747429
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.
Nik-Ahd F; Lenore Ackerman A; Anger J
Curr Urol Rep; 2018 Sep; 19(11):94. PubMed ID: 30215140
[TBL] [Abstract][Full Text] [Related]
19. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
20. The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women.
Chughtai B; Forde JC; Buck J; Asfaw T; Lee R; Te AE; Kaplan SA
Post Reprod Health; 2016 Mar; 22(1):34-40. PubMed ID: 26883688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
